Bristol-myers Squibb

This study is testing the safety and effectiveness of a two-drug combination (nivolumab + relatlimab) for people in India with advanced melanoma that cannot be removed by surgery or has spread. The study will enroll 30 participants who have not received any prior treatment for th…

This study is testing an experimental drug called BMS-986504 for people with advanced solid tumors that have a specific genetic change called an MTAP deletion. The trial will see if the drug works better when given alone or in combination with other cancer drugs. Researchers will…

This study aims to understand the long-term safety of the drug Admilparant in people with pulmonary fibrosis, a serious lung scarring disease. It will follow over 2,200 patients who have already taken the drug in previous clinical trials. The main goal is to monitor for any side …

This study is testing whether a new drug called pumitamig works better than the current standard treatment (durvalumab) for people with stage III non-small cell lung cancer that cannot be surgically removed. The trial will involve 850 participants whose cancer hasn't progressed a…

This early-stage study aims to check the safety and measure drug levels of an experimental medication called BMS-986454 in people with rheumatoid arthritis. The trial will enroll 46 participants whose arthritis didn't fully respond to standard methotrexate treatment. Researchers …

This study aims to see if a new drug called pumitamig works better than the current standard treatment (pembrolizumab) for people with advanced non-small cell lung cancer. It will involve 750 adults who have not yet received treatment for their advanced cancer and whose tumors ha…

This early-stage study is the first time a new drug called BMS-986528 will be tested in people. It aims to see if the drug is safe and if it can help control rheumatoid arthritis in adults whose disease hasn't improved with other treatments. Researchers will closely monitor how t…

This study aims to see if a two-drug combination called KarXT + KarX-EC can safely reduce severe irritability in children and adolescents with autism. It will involve 176 participants aged 5 to 17. Researchers will compare the effects of the medication to a placebo over 8 weeks t…

This study aims to see if a two-drug combination called KarXT + KarX-EC can safely reduce severe irritability in children and adolescents with autism. It will involve 176 participants aged 5 to 17. Researchers will compare the effects of the treatment to a placebo over 8 weeks to…

This early-stage study aims to understand how a new drug called BMS-986435 behaves in the body of people with normal liver function compared to those with mild or moderate liver impairment. The trial will involve 24 participants who will receive a single dose of the drug, then re…

This study aims to understand the safety of the ulcerative colitis medication ozanimod when taken during pregnancy. It will follow pregnant women with UC who are taking ozanimod to see if it affects the health of the mother or the baby. The study is observational, meaning it coll…

This study aims to collect and analyze real-world information about patients in Asia diagnosed with myelodysplastic syndromes (MDS), a type of blood and bone marrow cancer. It will enroll up to 500 adults who were recently diagnosed, gathering details about their health, treatmen…